Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026)

Zimmer Biomet Holdings (ZBH) recorded quarterly Other Non-Current Liabilities of $630.7 million in Q1 2026, up 0.73% quarter-over-quarter from $626.1 million in Q4 2025, and up 358.02% on a YoY basis from $137.7 million in Q1 2025.

Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $630.7 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities rose 358.02% year-over-year to $630.7 million; the TTM figure through Mar 2026 stood at $630.7 million (up 358.02% YoY), while the FY2025 annual figure was $626.1 million, up 246.49% from the prior year.
  • Other Non-Current Liabilities was $630.7 million for Q1 2026 at Zimmer Biomet Holdings, up from $626.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.2 billion in Q2 2024 to a low of $137.7 million in Q1 2025.
  • Historically, Other Non-Current Liabilities has averaged $665.1 million across 5 years, with a median of $631.9 million in 2023.
  • The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities plunged 80.48% in 2024, then soared 358.02% in 2026.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $632.6 million in 2022, then jumped by 46.35% to $925.8 million in 2023, then slumped by 80.48% to $180.7 million in 2024, then surged by 246.49% to $626.1 million in 2025, then climbed by 0.73% to $630.7 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $630.7 million (Q1 2026), $626.1 million (Q4 2025), and $806.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 630.70 Mn
Dec 31, 2025 626.10 Mn
Sep 30, 2025 806.40 Mn
Jun 30, 2025 878.80 Mn
Mar 31, 2025 137.70 Mn
Dec 31, 2024 180.70 Mn
Sep 30, 2024 1.03 Bn
Jun 30, 2024 1.21 Bn
Mar 31, 2024 577.00 Mn
Dec 31, 2023 925.80 Mn
Sep 30, 2023 631.90 Mn
Jun 30, 2023 642.00 Mn
Mar 31, 2023 637.40 Mn
Dec 31, 2022 632.60 Mn
Sep 30, 2022 581.30 Mn
Jun 30, 2022 591.00 Mn
Mar 31, 2022 593.10 Mn
Dec 31, 2021 548.50 Mn
Sep 30, 2021 606.70 Mn
Jun 30, 2021 581.60 Mn